January 20, 2009 10:21 AM
- Text
Pfizer's New Rat-Vomit Ad Raises Questions About Where Drugs Really Come From
(MoneyWatch) Pfizer has launched a scary new ad (see below) warning people of the dangers of buying pharmaceuticals without a prescription. The ad -- which shows a man taking a pill and then vomiting up a dead rat -- asks consumers to not buy medicines without prescriptions from websites because the unregulated, unchecked ingredients may be poisonous.
The ad is a good one -- buying pills from websites is a stupid idea. But it also raises an awkward question for Pfizer, where do its medicines come from? CEO Jeff Kindler told investors in October that he expected Pfizer to be "in" 137 cities in China by the end of 2008. It wasn't clear whether those cities would contain factories, R&D sites or offices for sales rep managers.
At the same time, the FDA is planning to increase the number of inspectors in China -- to just twelve people. Those inspectors can inspect only 80 factories a year.
It's not just Pfizer. Europe's only manufacturer of paracetemol recently closed its last factory in France and moved to China and India. Multiply that trend across all drug manufacturers and you can quickly see that the chances of getting your Chinese drug factory inspected by the FDA in a given year are small.
Should you be concerned? Yes. At least 103 people were killed by adulterated heparin produced in Chinese factories. Baxter is currently being sued in the U.S. in a consumer fraud action over the incident.
More generally, it leaves the U.S. dependent on foreign countries who are not always our allies for our medicines. The NY Times points out:
The ad is a good one -- buying pills from websites is a stupid idea. But it also raises an awkward question for Pfizer, where do its medicines come from? CEO Jeff Kindler told investors in October that he expected Pfizer to be "in" 137 cities in China by the end of 2008. It wasn't clear whether those cities would contain factories, R&D sites or offices for sales rep managers.
At the same time, the FDA is planning to increase the number of inspectors in China -- to just twelve people. Those inspectors can inspect only 80 factories a year.
It's not just Pfizer. Europe's only manufacturer of paracetemol recently closed its last factory in France and moved to China and India. Multiply that trend across all drug manufacturers and you can quickly see that the chances of getting your Chinese drug factory inspected by the FDA in a given year are small.
Should you be concerned? Yes. At least 103 people were killed by adulterated heparin produced in Chinese factories. Baxter is currently being sued in the U.S. in a consumer fraud action over the incident.
More generally, it leaves the U.S. dependent on foreign countries who are not always our allies for our medicines. The NY Times points out:
"The lack of regulation around outsourcing is a blind spot that leaves room for supply disruptions, counterfeit medicines, even bioterrorism," said Senator Sherrod Brown, Democrat of OhioSo, back to Pfizer's rat-vomit ad -- it makes a good point. But it would be nice if Pfizer also located its manufacturing facilities in places where English-speaking health inspectors could look at them.
Latest Now in MoneyWatch
- $25B foreclosure-abuse settlement reached
- Wholesale inventories rose 1 percent in December
- States, Feds to announce new mortgage settlement
- Management changes at Ford
- Unemployment aid applications near a 4-year low
- PepsiCo's net rises; plans to cut 8,700 jobs
- Smartr: A brilliant contacts app for smartphones
- What happens if your insurance company fails?
- Student loan debt: The next financial disaster?
- Investing: Four words that can rob you blind
- How to get the fastest tax refund
- Last year's losers are winning this year
- 10 employee types that drive managers crazy
- How leaders know it's time to quit
- Greece fails to agree terms with EU creditors
- 5 banks in $26B settlement with feds over abuses
- Gas prices continue to creep up
Latest CBS News Headlines
on Facebook
on CBS News
- Broadway set to tell the tale of Magic and Bird
- AG: Illinois to get $1B in mortgage settlement
- APNewsBreak: Official: 10 states get ed waiver
- Why "The Rock" craves return to wrestling ring
on Facebook
- Mo. teen gets life in prison for murder of 9-year-old girl
- Calif. surfer runs fastest-growing camera company
- "Person to Person": Bon Jovi behind the scenes
- "American Idol": Jim Carrey's daughter out, and then disaster
on CBS News






